SE8502876L - Inhibering av tumorutveckling - Google Patents

Inhibering av tumorutveckling

Info

Publication number
SE8502876L
SE8502876L SE8502876A SE8502876A SE8502876L SE 8502876 L SE8502876 L SE 8502876L SE 8502876 A SE8502876 A SE 8502876A SE 8502876 A SE8502876 A SE 8502876A SE 8502876 L SE8502876 L SE 8502876L
Authority
SE
Sweden
Prior art keywords
tumor development
development inhibition
vitro
tumor
toxic
Prior art date
Application number
SE8502876A
Other languages
Unknown language ( )
English (en)
Other versions
SE8502876D0 (sv
SE468501B (sv
Inventor
A Gaffar
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of SE8502876D0 publication Critical patent/SE8502876D0/sv
Publication of SE8502876L publication Critical patent/SE8502876L/sv
Publication of SE468501B publication Critical patent/SE468501B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8502876A 1984-06-27 1985-06-11 Anvaendning av derivat av peroxidifosforsyra foer inhibering av tumoerutveckling SE468501B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62506784A 1984-06-27 1984-06-27
US72654585A 1985-04-24 1985-04-24

Publications (3)

Publication Number Publication Date
SE8502876D0 SE8502876D0 (sv) 1985-06-11
SE8502876L true SE8502876L (sv) 1985-12-28
SE468501B SE468501B (sv) 1993-02-01

Family

ID=27089811

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8502876A SE468501B (sv) 1984-06-27 1985-06-11 Anvaendning av derivat av peroxidifosforsyra foer inhibering av tumoerutveckling

Country Status (26)

Country Link
JP (1) JPH0623108B2 (sv)
KR (1) KR880002266B1 (sv)
AT (1) AT392002B (sv)
AU (1) AU578104B2 (sv)
BE (1) BE902732A (sv)
CH (1) CH668361A5 (sv)
DE (1) DE3523263A1 (sv)
DK (1) DK168191B1 (sv)
ES (1) ES8801122A1 (sv)
FI (1) FI84697C (sv)
FR (1) FR2566665B1 (sv)
GB (1) GB2161074B (sv)
GR (1) GR851575B (sv)
IE (1) IE58434B1 (sv)
IL (1) IL75518A0 (sv)
IT (1) IT1209961B (sv)
LU (1) LU85976A1 (sv)
MA (1) MA20467A1 (sv)
MC (1) MC1672A1 (sv)
NL (1) NL8501840A (sv)
NZ (1) NZ212301A (sv)
PH (1) PH25613A (sv)
PT (1) PT80707B (sv)
SE (1) SE468501B (sv)
WO (1) WO1986000225A1 (sv)
ZW (1) ZW9585A1 (sv)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3528379A1 (de) * 1985-08-07 1987-02-12 Peter Berger Mittel zur behandlung waessriger systeme sowie zur regenerierung von koerperzellen
FR2586350B1 (fr) * 1985-08-22 1992-05-15 Colgate Palmolive Co Composition pharmaceutique a base de peroxodiphosphate pour l'inhibition de la secretion d'hormone parathyroidienne
DE3627759A1 (de) * 1985-08-22 1987-03-19 Colgate Palmolive Co Pharmazeutische zusammensetzung zum inaktivieren bakterieller endotoxine
DE4201858A1 (de) * 1992-01-24 1993-07-29 Renschler Aloys Dr Med Mittel zur behandlung maligner zellen
KR100426450B1 (ko) * 2002-03-16 2004-04-13 박래옥 구연산, 알부민 및 아연을 함유한 항암 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4041149A (en) * 1976-01-12 1977-08-09 Colgate-Palmolive Company Composition and method of controlling and preventing mouth odor
US4430325A (en) * 1981-12-23 1984-02-07 Colgate-Palmolive Company Topical treatment of skin lesions

Also Published As

Publication number Publication date
ATA188385A (de) 1990-07-15
GB8515105D0 (en) 1985-07-17
JPS6140217A (ja) 1986-02-26
NL8501840A (nl) 1986-01-16
KR860000070A (ko) 1986-01-25
IT8548226A0 (it) 1985-06-17
GR851575B (sv) 1985-11-25
GB2161074B (en) 1988-04-07
IE58434B1 (en) 1993-09-22
GB2161074A (en) 1986-01-08
FI852504L (fi) 1985-12-28
MA20467A1 (fr) 1985-12-31
SE8502876D0 (sv) 1985-06-11
BE902732A (fr) 1985-12-24
JPH0623108B2 (ja) 1994-03-30
ES544565A0 (es) 1988-01-01
NZ212301A (en) 1988-04-29
IE851597L (en) 1985-12-27
ZW9585A1 (en) 1985-11-13
AU578104B2 (en) 1988-10-13
PT80707B (en) 1986-12-09
FI84697B (fi) 1991-09-30
IT1209961B (it) 1989-08-30
ES8801122A1 (es) 1988-01-01
CH668361A5 (de) 1988-12-30
MC1672A1 (fr) 1986-06-03
FI852504A0 (fi) 1985-06-25
PH25613A (en) 1991-08-08
DK168191B1 (da) 1994-02-28
AT392002B (de) 1991-01-10
PT80707A (en) 1985-07-01
LU85976A1 (fr) 1986-01-24
IL75518A0 (en) 1985-10-31
SE468501B (sv) 1993-02-01
KR880002266B1 (ko) 1988-10-21
AU4418785A (en) 1986-01-02
FR2566665B1 (fr) 1988-10-21
FR2566665A1 (fr) 1986-01-03
FI84697C (sv) 1992-01-10
DE3523263A1 (de) 1986-01-09
DK248085D0 (da) 1985-06-03
WO1986000225A1 (en) 1986-01-16
DK248085A (da) 1985-12-28

Similar Documents

Publication Publication Date Title
LU88576I2 (fr) RISPERIDONE et ses sels pharmaceutiquement acceptables (Risperdal R)
LU90829I2 (fr) Tepoxalin-zubrin et ses d-riv-s pharmaceutiquement acceptables
LU90219I2 (fr) Tolcapone et ses dérivés pharmaceutiquement acceptables (TASMAR)
LU91039I2 (fr) Proteq flu et ses dérivés pharmaceutiquement acceptables
NO863061L (no) Fremgangsmaate for fremstilling av fysiologisk aktive fenoksyeddiksyrederivater.
LU90484I2 (fr) Novorapid - insuline asparte et ses sels et derives pharmaceutiquement acceptables
NL194821B (nl) Farmacologisch actieve catecholderivaten en samenstellingen ervan.
NO821645L (no) Analogifremgangsmaate for fremstilling av farmakologisk aktive benzoazepinderivater
DK356085A (da) Reninhaemmende peptid eller et farmaceutisk acceptabelt syreadditionssalt deraf
NO864425D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocyklyloksoftalazinyl-eddiksyre-derivater.
NO161373C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pteridin-derivater.
NO852729L (no) Fremgangsmaate for fremstilling av terapeutisk virksomme benzimidazol- og benzotiazolderivater
LU88790I2 (fr) Moxidectin et ses dérivés pharmaceutiquement acceptables
DE3263917D1 (en) Alkanesulfonanilide derivatives and pharmaceutically acceptable acid addition salts thereof
NO851679L (no) Fremgangsmaate for fremstilling av fysiologisk aktive fenol-derivater.
NO854369L (no) Fremgangsmaate for fremstilling av terapeutisk aktive benzimidazol-derivater
DK0599914T3 (da) Farmakologiske forbedrede formuleringer
SE8502876L (sv) Inhibering av tumorutveckling
IT1151953B (it) Composizione farmaceutica per la cura di affezioni della cavita' orale
JO1451B1 (en) Stopping the development (growth) of diseases
IT1143921B (it) Derivati di acidi alcanoici dotati di proprieta' terapeutiche e procedimento per la loro preparazione
IT1157126B (it) N(vinblastin-23-il)derivati di aminoacidi loro preparazione ed applicazione terapeutica
NO166322C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nitroapovincaminsyrederivater.
IT1096279B (it) Composto farmaceutico di migliorata attivita'mucolitica e fluidificante delle secrezioni mucose
NO852741L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 5,6-dihydro-4h-cyklopenta (b)tiofen-6-karboksylsyre-derivater

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8502876-9

Effective date: 19950110

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8502876-9

Format of ref document f/p: F